| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the
1 From the Laboratory of Chemical Pharmacology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20014
Transport of methotrexate (4-amino-10-methylpteroyl-glutamic acid), a structural analogue of folic acid, was studied in L1210 mouse leukemia cells grown in tissue culture. Intracellular methotrexate was present in two states. (a) There was an essentially nonexchangeable intracellular fraction probably bound to the enzyme dihydrofolate reductase. (b) The remaining intracellular methotrexate was rapidly exchangeable and likely present in the cell water in an osmotically active state. In addition, there was a small rapidly exchanging component of methotrexate associated with the cells which had the characteristics of a loose adsorption on or near to the cell membrane. Methotrexate was shown to be negligibly metabolized by this cell system. Because of the presence of tight intracellular binding sites for methotrexate, prior to saturation of these sites, free intracellular methotrexate does not appear and consequently efflux is negligible. This permits the accurate measurement of unidirectional uptake velocities. The major portion of the unidirectional influx process demonstrated Michaelis-Menten kinetics with a high degree of structural specificity, competitive inhibition by folic and folinic acids, and marked temperature dependence. Addition of these competing substances in excess to cells at the steady state with extracellular methotrexate leads to countertransport of intracellular methotrexate. Electrochemical potential gradients for free intracellular methotrexate were demonstrated at low levels of extracellular methotrexate and intracellular methotrexate concentrations at equilibrium exhibited Michaelis-Menten kinetics. Efflux of intracellular methotrexate was not first order and appeared to be partially saturated. The Michaelis constant and maximum velocity for the unidirectional efflux process were estimated, and when related to these parameters for the unidirectional influx, were compatible with an accumulating system. These studies indicate that methotrexate transport in the L1210 cell is carrier-mediated and uphill. Methotrexate exhibits several qualities which make it a valuable "model substrate" for the study of the transport characteristics of folic acid and its naturally occurring derivatives. The implication of these findings with respect to the development of more effective folic acid antagonists is considered.
Carrier-mediated Transport of the Folic Acid Analogue, Methotrexate, in the L1210 Leukemia Cell
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Deng, Z. Hou, L. Wang, C. Cherian, J. Wu, A. Gangjee, and L. H. Matherly Role of Lysine 411 in Substrate Carboxyl Group Binding to the Human Reduced Folate Carrier, as Determined by Site-Directed Mutagenesis and Affinity Inhibition Mol. Pharmacol., April 1, 2008; 73(4): 1274 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chattopadhyay, R. G. Moran, and I. D. Goldman Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications Mol. Cancer Ther., February 1, 2007; 6(2): 404 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, A. Rajgopal, I. D. Goldman, and R. Zhao Preservation of folate transport activity with a low-pH optimum in rat IEC-6 intestinal epithelial cell lines that lack reduced folate carrier function Am J Physiol Cell Physiol, January 1, 2005; 288(1): C65 - C71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. McCarthy, S. A. Titus, S. M. Taylor, C. Jackson-Cook, and R. G. Moran A Mutation Inactivating the Mitochondrial Inner Membrane Folate Transporter Creates a Glycine Requirement for Survival of Chinese Hamster Cells J. Biol. Chem., August 6, 2004; 279(32): 33829 - 33836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Theti and A. L. Jackman The Role of {alpha}-Folate Receptor-Mediated Transport in the Antitumor Activity of Antifolate Drugs Clin. Cancer Res., February 1, 2004; 10(3): 1080 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Trippett, S. Garcia, K. Manova, R. Mody, L. Cohen-Gould, W. Flintoff, and J. R. Bertino Localization of a Human Reduced Folate Carrier Protein in the Mitochondrial as Well as the Cell Membrane of Leukemia Cells Cancer Res., March 1, 2001; 61(5): 1941 - 1947. [Abstract] [Full Text]
|
|
|
|
|
|
R. Zhao, S. Babani, F. Gao, L. Liu, and I. D. Goldman The Mechanism of Transport of the Multitargeted Antifolate (MTA) and Its Cross-resistance Pattern in Cells with Markedly Impaired Transport of Methotrexate Clin. Cancer Res., September 1, 2000; 6(9): 3687 - 3695. [Abstract] [Full Text]
|
|
|
|
|
|
F. B. Turner, J. L. Andreassi II, J. Ferguson, S. Titus, A. Tse, S. M. Taylor, and R. G. Moran Tissue-specific Expression of Functional Isoforms of Mouse Folylpoly-{{gamma}}-glutamate Synthetase: A Basis for Targeting Folate Antimetabolites Cancer Res., December 1, 1999; 59(24): 6074 - 6079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Barnes, E. J. Estlin, G. A. Taylor, G. W. Aherne, A. Hardcastle, J. J. McGuire, J. A. Calvete, J. Lunec, A. D. J. Pearson, and D. R. Newell Impact of Polyglutamation on Sensitivity to Raltitrexed and Methotrexate in Relation to Drug-induced Inhibition of de Novo Thymidylate and Purine Biosynthesis in CCRF-CEM Cell Lines Clin. Cancer Res., September 1, 1999; 5(9): 2548 - 2558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tse and R. G. Moran Cellular Folates Prevent Polyglutamation of 5,10-Dideazatetrahydrofolate. A NOVEL MECHANISM OF RESISTANCE TO FOLATE ANTIMETABOLITES J. Biol. Chem., October 2, 1998; 273(40): 25944 - 25952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tse, K. Brigle, S. M. Taylor, and R. G. Moran Mutations in the Reduced Folate Carrier Gene Which Confer Dominant Resistance to 5,10-Dideazatetrahydrofolate J. Biol. Chem., October 2, 1998; 273(40): 25953 - 25960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zhao, Y. G. Assaraf, and I. D. Goldman A Mutated Murine Reduced Folate Carrier (RFC1) with Increased Affinity for Folic Acid, Decreased Affinity for Methotrexate, and an Obligatory Anion Requirement for Transport Function J. Biol. Chem., July 24, 1998; 273(30): 19065 - 19071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zhao, R. Seither, K. E. Brigle, I. G. Sharina, P. J. Wang, and I. D. Goldman Impact of Overexpression of the Reduced Folate Carrier (RFC1), an Anion Exchanger, on Concentrative Transport in Murine L1210 Leukemia Cells J. Biol. Chem., August 22, 1997; 272(34): 21207 - 21212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Brigle, M. J. Spinella, E. E. Sierra, and I. D. Goldman Characterization of a Mutation in the Reduced Folate Carrier in a Transport Defective L1210 Murine Leukemia Cell Line J. Biol. Chem., September 29, 1995; 270(39): 22974 - 22979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Spinella, K. E. Brigle, E. E. Sierra, and I. D. Goldman Distinguishing between Folate Receptor-alpha-mediated Transport and Reduced Folate Carrier-mediated Transport in L1210 Leukemia Cells J. Biol. Chem., April 7, 1995; 270(14): 7842 - 7849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Goldenberg, C. L. Vanstone, and I. Bihler Transport of Nitrogen Mustard on the Transport-Carrier for Choline in L5178Y Lymphoblasts Science, June 11, 1971; 172(3988): 1148 - 1149. [Abstract] [PDF]
|
|
|
|
|
|
R. Zhao, R. G. Russell, Y. Wang, L. Liu, F. Gao, B. Kneitz, W. Edelmann, and I. D. Goldman Rescue of Embryonic Lethality in Reduced Folate Carrier-deficient Mice by Maternal Folic Acid Supplementation Reveals Early Neonatal Failure of Hematopoietic Organs J. Biol. Chem., March 23, 2001; 276(13): 10224 - 10228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Titus and R. G. Moran Retrovirally Mediated Complementation of the glyB Phenotype. CLONING OF A HUMAN GENE ENCODING THE CARRIER FOR ENTRY OF FOLATES INTO MITOCHONDRIA J. Biol. Chem., November 17, 2000; 275(47): 36811 - 36817. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |
